Lentiviral hematopoietic stem cell gene therapy for Metachromatic Leukodystrophy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lentiviral hematopoietic stem cell gene therapy for Metachromatic Leukodystrophy, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD [NA]

See pricing